These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6414186)

  • 21. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant.
    Prowse C; Waterston YG; Dawes J; Farrugia A
    Vox Sang; 1987; 52(4):257-64. PubMed ID: 3114954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in blood coagulation and fibrinolysis in the normal puerperium.
    Dahlman T; Hellgren M; Blombäck M
    Gynecol Obstet Invest; 1985; 20(1):37-44. PubMed ID: 3930349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S; Cattaneo M; Gervasoni W; Mannucci PM
    Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days.
    Smak Gregoor PJ; Harvey MS; Briët E; Brand A
    Transfusion; 1993 Sep; 33(9):735-8. PubMed ID: 8212120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of the factor VIII complex.
    Thorell L; Blombäck B
    Thromb Res; 1984 Aug; 35(4):431-50. PubMed ID: 6435279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimers of von Willebrand antigen in therapeutic factor VIII concentrates.
    Vukovich TC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):831-40. PubMed ID: 2436998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factor VIII complex activities in acute leukemia].
    Pniejnia-Olszyński W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness, specificity and safety of intranasal 1-deamino-8-D-arginine vasopressin treatment of normal blood donors.
    Palmer DS; Harris AS; Tittley P; Rock G
    Haemostasis; 1988; 18(3):187-96. PubMed ID: 2972594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and degradation of fibrinopeptide A in stored platelet concentrate.
    Bode AP; Miller DT
    Vox Sang; 1986; 51(3):192-6. PubMed ID: 3811318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
    Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
    Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of complement and coagulation in juvenile dermatomyositis.
    Scott JP; Arroyave C
    Arthritis Rheum; 1987 May; 30(5):572-6. PubMed ID: 3109444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of canine factor VIII activity and von Willebrand factor antigen concentration in vitro.
    Mansell PD; Parry BW
    Res Vet Sci; 1991 Nov; 51(3):313-6. PubMed ID: 1780587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure?
    Bertaglia E; Belmonte P; Vertolli U; Azzurro M; Martines D
    Haemostasis; 1983; 13(5):328-34. PubMed ID: 6418623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro characterization of various factor VIII concentrates.
    Yoshioka A; Shima M; Nishino M; Yoshikawa N; Fukui H
    Arzneimittelforschung; 1987 Jul; 37(7):753-6. PubMed ID: 3118888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemostatic variables in patients with unstable angina.
    al-Nozha M; Gader AM; al-Momen AK; Noah MS; Jawaid M; Arafa M
    Int J Cardiol; 1994 Mar; 43(3):269-77. PubMed ID: 8181885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

  • 40. Factor VIIIR:Ag/Factor VIII:C and their ratio in obstetrical cases.
    Caires D; Arocha-Pinango CL; Rodriguez S; Linares J
    Acta Obstet Gynecol Scand; 1984; 63(5):411-6. PubMed ID: 6437129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.